ROCKVILLE, Md., Feb. 10, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer of Novavax, will be presenting at the 14th Annual Bio CEO & Investor Conference in New York on Monday, February 13th at 4:00pm. A live audio-only webcast link for the presentation can be accessed via the company website at www.novavax.com under Investor Info/Events.
